Document is current
Any future updates will be listed below
-
Authors
Yamaguchi, Shogo
Uemura, Yusuke https://orcid.org/0000-0002-2262-1452
Tanaka, Akihito
Takagi, Kensuke
Ohashi, Taiki
Tanaka, Miho
Umemoto, Norio
Yoshida, Ruka
Negishi, Yosuke
Iwama, Makoto
Takemoto, Kenji
Watarai, Masato
Kudo, Nobutaka
Morishima, Itsuro
Tatami, Yosuke
Takada, Yasunobu
Shimizu, Kiyokazu
Yoshida, Yukihiko
Tanaka, Toshikazu
Noda, Toshiyuki
Ishii, Hideki
Murohara, Toyoaki
,
- License Information
-
More Information
Article History
Received: 24 March 2022
Accepted: 20 July 2022
First Online: 10 August 2022
Declarations
:
: Hideki Ishii received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc., and MSD K. K. Yusuke Uemura received lecture fees from Otsuka Pharma Ltd. Toyoaki Murohara received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. Toyoaki Murohara received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
